ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
0,00%
Dow Jones
39 872,99
0,17%
DAX
18 726,76
-0,21%
Brent Oil
82,145
-0,36%
Bitcoin
69 862,71
-0,39%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Onward Opportunities Limited (ONWD)

  7. Onward Opportunities Limited (ONWD) Actualités

ONWD Onward Opportunities Limited

115,50
0,00 (0,00%)
21 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Onward Opportunities Limited ONWD London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 115,50 09:00:05
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
116,00 115,50 116,00 115,50 115,50
plus d'informations sur les cotations »
Secteur Industriel
PHARMACEUTICALS & BIOTECHNOLOGY

Actualités Recentes

Date Heure Source Titre
21/5/202418:25GLOBEONWARD® Medical to Host Webcast to Share Details from its..
20/5/202417:35GLOBENature Medicine Highlights Significant Improvement in Hand..
15/5/202400:21GLOBEONWARD® Medical Schedules Webcast to Provide Q1 2024..
08/5/202408:00UK RNSOnward Opportunities Limited Posting of Annual Report and..
07/5/202408:00UK RNSOnward Opportunities Limited Net Asset Value(s)
02/5/202407:00GLOBEONWARD® Medical Convocation of the 2024 Annual General..
26/4/202408:00UK RNSOnward Opportunities Limited Issue of Equity/Director/PDMR..
25/4/202407:30GLOBEONWARD® Medical Reports Full Year 2023 Financial and..
11/4/202412:39ALNCNewsOnward Opportunities' small-cap strategy yields solid..
11/4/202408:00UK RNSOnward Opportunities Limited Annual Results
11/4/202407:30GLOBEONWARD® Medical Announces Publication of Full Year 2023..
09/4/202407:00GLOBEStifel Initiates Research Coverage of ONWARD® Medical with a..
03/4/202408:00UK RNSOnward Opportunities Limited Net Asset Value(s)
02/4/202407:30GLOBEONWARD® Medical Submits De Novo Application to FDA for its..
28/3/202417:51UK RNSOnward Opportunities Limited Holding(s) in Company
28/3/202411:28ALNCNewsTRADING UPDATES: Develop North net asset value down amid..
26/3/202408:00UK RNSOnward Opportunities Limited Issue of Equity
25/3/202417:40GLOBEONWARD® Medical Publishes Closing of Accelerated Bookbuild..
21/3/202418:26GLOBEONWARD® Medical Publishes Prospectus for Listing of New..
21/3/202403:03GLOBEONWARD® Medical Successfully Raises €20 Million in a Capital..
20/3/202418:29GLOBEONWARD® Medical Launches Capital Increase by Way of an..
20/3/202418:24GLOBEONWARD® Medical Launches Capital Increase by Way of an..
18/3/202407:30UKREGONWARD® Medical Successfully Completes Benchmark Testing on..
15/3/202407:30UKREGONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic..
11/3/202407:30UKREGONWARD® Medical Accepted to New US FDA TAP Program for..
05/3/202416:21UK RNSOnward Opportunities Limited Net Asset Value(s)
29/2/202407:41UKREGONWARD® Medical Awarded 10th Breakthrough Device Designation..
22/2/202415:20UK RNSOnward Opportunities Limited Director/PDMR Shareholding
09/2/202407:30UKREGKBC Securities Initiates Research Coverage of ONWARD®..
07/2/202421:55UKREGONWARD® MEDICAL ANNOUNCES PRESENTATION AT BIOCAPITAL EUROPE
02/2/202408:00UK RNSOnward Opportunities Limited Net Asset Value(s)
25/1/202423:11UKREGONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of..
22/1/202420:03GLOBEONWARD® to Participate in Basel Healthtech Conference 2024
19/1/202418:48GLOBEONWARD® to Participate in Degroof Petercam Healthcare..
18/1/202411:44UKREGOnward Opportunities Limited Holding(s) in Company
18/1/202407:30GLOBEONWARD® Announces Start of HemON NL Clinical Study
10/1/202414:04ALNCNewsOnward Opportunities net assets up, 2024 income to offset..
10/1/202408:00UKREGOnward Opportunities Limited Portfolio Update
10/1/202408:00UKREGOnward Opportunities Limited Quarterly Factsheet -- Q4 2023
04/1/202408:00UKREGOnward Opportunities Limited Net Asset Value(s)
18/12/202312:26UKREGOnward Opportunities Limited Holding(s) in Company
04/12/202316:19UKREGOnward Opportunities Limited Net Asset Value(s)
16/11/202307:30GLOBEONWARD® Reports Q3 Business Update and Year-To-Date..
06/11/202318:13GLOBENature Medicine Publication Highlights Potential for ONWARD®..
03/11/202316:14UKREGOnward Opportunities Limited Net Asset Value(s)
31/10/202313:00UKREGOnward Opportunities Limited TVR & Change of Nominated..
24/10/202321:21ALNCNewsTRADING UPDATES: System1 revenue jumps; Volex takes cyber..
24/10/202308:05UKREGOnward Opportunities Limited Quarterly Factsheet - Q3 2023
11/10/202319:43GLOBEONWARD Schedules Webcast to Provide Third Quarter 2023..
11/10/202318:39UKREGOnward Opportunities Limited Holding(s) in Company

Dernières Valeurs Consultées

LSE
ONWD
Onward Opportunities
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés